Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC), 6634 [E9-2805]

Download as PDF 6634 Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices Dated: February 3, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E9–2805 Filed 2–9–09; 8:45 am] Dated: February 2, 2009. Carolyn M. Clancy, Director. [FR Doc. E9–2680 Filed 2–9–09; 8:45 am] BILLING CODE 4160–90–M BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC) erowe on PROD1PC63 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned committee: Time and Date: 3 p.m.–4:30 p.m., February 24, 2009. Place: The teleconference call will originate at the CDC. For details on accessing the teleconference is located in the supplementary information. Status: Open to the public, teleconference access limited only by availability of telephone ports. Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC. Matters to be Discussed: The Advisory Committee to the Director will discuss and decide on recommendations from its Ethics Subcommittee, National Biosurveillance Advisory Subcommittee, and Budget Workgroup. The Ethics Subcommittee will make recommendations on using travel restrictions for individuals with infectious illnesses. The Ethics Subcommittee will also discuss a draft charge that clearly articulates the ethical foundation for focusing on health protection activities and examining the social determinants of health. The National Biosurveillance Advisory Subcommittee will seek approval on recommendations for latitude to share specific points with key members of the new administration. The Budget Workgroup will provide recommendations around principles for change, in terms of the budget and the budget structure and process for the CDC. Agenda items are subject to change as priorities dictate. Supplementary Information: This conference call is scheduled to begin at 3 p.m. Eastern Standard Time. To participate in the teleconference, please dial 1 (888) 323–9787 and enter conference code 4735949. Contact Person for More Information: Brad Perkins, M.D., M.B.A., Executive Officer, ACD, CDC, 1600 Clifton Road, NE., M/S D– 14, Atlanta, Georgia 30333. Telephone: (404) 639–7000. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry. VerDate Nov<24>2008 14:17 Feb 09, 2009 Jkt 217001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Assessing the Accuracy of Self-Report of HIV Testing Behavior, Program Announcement Number (PA) 09–002 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 8 a.m.–5 p.m., March 20, 2009 (Closed). Place: Sheraton Gateway Hotel, Atlanta Airport, 1900 Sullivan Road, Atlanta, GA 30337, Telephone (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Assessing the Accuracy of Self-Report of HIV Testing Behavior, Program Announcement Number (PA) 09–002.’’ Contact Person for More Information: Gregory Anderson, M.P.H., M.S., Scientific Review Administrator, Strategic Science and Program Unit, Office of the Director, Coordinating Center for Infectious Diseases, CDC, 1600 Clifton Road, Mailstop E–60, Atlanta, GA 30333, Telephone: (404) 498– 2275. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 3, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–2803 Filed 2–9–09; 8:45 am] Frm 00066 Fmt 4703 Food and Drug Administration [Docket No. FDA–2008–D–0339] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products and Antimicrobial Susceptibility Testing Devices AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by March 12, 2009. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–6974, or e-mailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–NEW and title ‘‘Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products and Antimicrobial Susceptibility Testing Devices.’’ Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of Information Management (HFA–710), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–796–3792. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products and Antimicrobial Susceptibility Testing Devices In the Federal Register of June 12, 2008 (73 FR 33438), FDA announced the availability of a draft guidance for BILLING CODE 4163–18–P PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES Sfmt 4703 E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 74, Number 26 (Tuesday, February 10, 2009)]
[Notices]
[Page 6634]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2805]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director, Centers for Disease Control 
and Prevention (ACD, CDC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the CDC announces the following meeting 
of the aforementioned committee:

    Time and Date: 3 p.m.-4:30 p.m., February 24, 2009.
    Place: The teleconference call will originate at the CDC. For 
details on accessing the teleconference is located in the 
supplementary information.
    Status: Open to the public, teleconference access limited only 
by availability of telephone ports.
    Purpose: The committee will provide advice to the CDC Director 
on strategic and other broad issues facing CDC.
    Matters to be Discussed: The Advisory Committee to the Director 
will discuss and decide on recommendations from its Ethics 
Subcommittee, National Biosurveillance Advisory Subcommittee, and 
Budget Workgroup. The Ethics Subcommittee will make recommendations 
on using travel restrictions for individuals with infectious 
illnesses. The Ethics Subcommittee will also discuss a draft charge 
that clearly articulates the ethical foundation for focusing on 
health protection activities and examining the social determinants 
of health. The National Biosurveillance Advisory Subcommittee will 
seek approval on recommendations for latitude to share specific 
points with key members of the new administration. The Budget 
Workgroup will provide recommendations around principles for change, 
in terms of the budget and the budget structure and process for the 
CDC.
    Agenda items are subject to change as priorities dictate.
    Supplementary Information: This conference call is scheduled to 
begin at 3 p.m. Eastern Standard Time. To participate in the 
teleconference, please dial 1 (888) 323-9787 and enter conference 
code 4735949.
    Contact Person for More Information: Brad Perkins, M.D., M.B.A., 
Executive Officer, ACD, CDC, 1600 Clifton Road, NE., M/S D-14, 
Atlanta, Georgia 30333. Telephone: (404) 639-7000.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. E9-2805 Filed 2-9-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.